2a1x
From Proteopedia
m (Protected "2a1x" [edit=sysop:move=sysop]) |
|||
Line 1: | Line 1: | ||
- | [[Image:2a1x.png|left|200px]] | ||
- | |||
{{STRUCTURE_2a1x| PDB=2a1x | SCENE= }} | {{STRUCTURE_2a1x| PDB=2a1x | SCENE= }} | ||
- | |||
===Human phytanoyl-coa 2-hydroxylase in complex with iron and 2-oxoglutarate=== | ===Human phytanoyl-coa 2-hydroxylase in complex with iron and 2-oxoglutarate=== | ||
+ | {{ABSTRACT_PUBMED_16186124}} | ||
- | + | ==Disease== | |
+ | [[http://www.uniprot.org/uniprot/PAHX_HUMAN PAHX_HUMAN]] Defects in PHYH are a cause of Refsum disease (RD) [MIM:[http://omim.org/entry/266500 266500]]. RD is an autosomal recessive disorder characterized clinically by a tetrad of abnormalities: retinitis pigmentosa, peripheral neuropathy, cerebellar ataxia, and elevated protein levels in the cerebrospinal fluid (CSF). Patients exhibit accumulation of the branched-chain fatty acid, phytanic acid, in blood and tissues. Less constant features are nerve deafness, anosmia, skeletal abnormalities, ichthyosis, cataracts and cardiac impairment. Manifestations of the disease appear in the second or third decade of life.<ref>PMID:9326939</ref><ref>PMID:9326940</ref><ref>PMID:10767344</ref><ref>PMID:10709665</ref> | ||
+ | |||
+ | ==Function== | ||
+ | [[http://www.uniprot.org/uniprot/PAHX_HUMAN PAHX_HUMAN]] Converts phytanoyl-CoA to 2-hydroxyphytanoyl-CoA. | ||
==About this Structure== | ==About this Structure== | ||
Line 11: | Line 13: | ||
==Reference== | ==Reference== | ||
- | <ref group="xtra">PMID:016186124</ref><references group="xtra"/> | + | <ref group="xtra">PMID:016186124</ref><references group="xtra"/><references/> |
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Phytanoyl-CoA dioxygenase]] | [[Category: Phytanoyl-CoA dioxygenase]] |
Revision as of 06:28, 25 March 2013
Contents |
Human phytanoyl-coa 2-hydroxylase in complex with iron and 2-oxoglutarate
Template:ABSTRACT PUBMED 16186124
Disease
[PAHX_HUMAN] Defects in PHYH are a cause of Refsum disease (RD) [MIM:266500]. RD is an autosomal recessive disorder characterized clinically by a tetrad of abnormalities: retinitis pigmentosa, peripheral neuropathy, cerebellar ataxia, and elevated protein levels in the cerebrospinal fluid (CSF). Patients exhibit accumulation of the branched-chain fatty acid, phytanic acid, in blood and tissues. Less constant features are nerve deafness, anosmia, skeletal abnormalities, ichthyosis, cataracts and cardiac impairment. Manifestations of the disease appear in the second or third decade of life.[1][2][3][4]
Function
[PAHX_HUMAN] Converts phytanoyl-CoA to 2-hydroxyphytanoyl-CoA.
About this Structure
2a1x is a 1 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
- McDonough MA, Kavanagh KL, Butler D, Searls T, Oppermann U, Schofield CJ. Structure of human phytanoyl-CoA 2-hydroxylase identifies molecular mechanisms of Refsum disease. J Biol Chem. 2005 Dec 9;280(49):41101-10. Epub 2005 Sep 25. PMID:16186124 doi:10.1074/jbc.M507528200
- ↑ Mihalik SJ, Morrell JC, Kim D, Sacksteder KA, Watkins PA, Gould SJ. Identification of PAHX, a Refsum disease gene. Nat Genet. 1997 Oct;17(2):185-9. PMID:9326939 doi:10.1038/ng1097-185
- ↑ Jansen GA, Ofman R, Ferdinandusse S, Ijlst L, Muijsers AO, Skjeldal OH, Stokke O, Jakobs C, Besley GT, Wraith JE, Wanders RJ. Refsum disease is caused by mutations in the phytanoyl-CoA hydroxylase gene. Nat Genet. 1997 Oct;17(2):190-3. PMID:9326940 doi:10.1038/ng1097-190
- ↑ Jansen GA, Hogenhout EM, Ferdinandusse S, Waterham HR, Ofman R, Jakobs C, Skjeldal OH, Wanders RJ. Human phytanoyl-CoA hydroxylase: resolution of the gene structure and the molecular basis of Refsum's disease. Hum Mol Genet. 2000 May 1;9(8):1195-200. PMID:10767344
- ↑ Jansen GA, Ferdinandusse S, Hogenhout EM, Verhoeven NM, Jakobs C, Wanders RJ. Phytanoyl-CoA hydroxylase deficiency. Enzymological and molecular basis of classical Refsum disease. Adv Exp Med Biol. 1999;466:371-6. PMID:10709665
Categories: Homo sapiens | Phytanoyl-CoA dioxygenase | Arrowsmith, C. | Bunkoczi, G. | Butler, D. | Delft, F Von. | Edwards, A. | Kavanagh, K L. | McDonough, M A. | Oppermann, U. | SGC, Structural Genomics Consortium. | Schofield, C J. | Searles, T. | Sundstrom, M. | Beta jelly roll | Double-stranded beta-helix | Oxidoreductase | Sgc | Structural genomic | Structural genomics consortium